Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Odanacatib
Odanacatib
Merck scraps development of osteoporosis drug due to stroke risk
Yahoo/Reuters
Fri, 09/2/16 - 09:47 am
Merck
osteoporosis
stroke
Odanacatib
Side effect fears weigh on Merck osteoporosis drug
Pharmaphorum
Tue, 09/16/14 - 10:25 am
Merck
osteoporosis
Odanacatib
Long-delayed Merck osteoporosis drug meets goal in study
Yahoo/Reuters
Mon, 09/15/14 - 04:31 pm
Merck
osteoporosis
Odanacatib
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib
Wall Street Cheat Street
Sun, 02/3/13 - 11:59 am
Merck
Odanacatib
osteoporosis
bone cancer
Merck says now anticipates odanacatib filing in 2014
Yahoo/Fly on the Wall
Fri, 02/1/13 - 10:55 am
Merck
Odanacatib
osteoarthritis
5 Drug Hopefuls That Are Going to Change Your Life: Part 3
Motley Fool
Sun, 12/9/12 - 11:29 am
Actonel
Reclast
Boniva
Warner Chilcott
Amgen
Prolia
Odanacatib
Merck
Novartis
GSK
Roche
Will Merck's Odanacatib Sufficiently Fill Singulair's Void?
Motley Fool
Sat, 12/1/12 - 09:23 am
Merck
Odanacatib
osteoporosis
Merck - How To Play This 'Patent Cliff' With Options
Seeking Alpha
Thu, 11/15/12 - 10:49 am
patent cliff
Merck
Singulair
Odanacatib
Maxalt
MK-3475
Merck osteoporosis drug builds bone density in mid-stage trial
Reuters
Sat, 10/13/12 - 12:31 pm
Merck
osteoporosis
Odanacatib
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Fri, 07/20/12 - 09:30 am
Merck
Abbott Labs
Amgen
GSK
Pfizer
Eli Lilly
osteoporosis
Odanacatib
Merck Hits 4-Year High As Osteoporosis Drug Shines
Investors.com
Thu, 07/12/12 - 11:23 am
Merck
osteoporosis
Odanacatib
Merck 's odanacatib potential overlooked, says Credit Suisse
Yahoo/Fly on the Wall
Mon, 06/25/12 - 11:03 am
Odanacatib
Merck
osteoporosis
Pipeline Checkup: Merck Has Potential
Motley Fool
Tue, 08/31/10 - 07:17 am
Merck
Vorapaxar
Boceprevir
Odanacatib
A look at some of Merck's key drugs in pipeline
Yahoo/AP
Wed, 05/12/10 - 09:29 am
Merck
pipelines
Anacetrapib
Vorapaxar
Odanacatib
Boceprevir
Preladenant
ridaforolimus